Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Hosvilda M 50/500mg Tablet
Manufacturer/Marketed By : HOSPIMAX HEALTHCARE PVT LTD
$0.90 $0.73
Hosvilda M 50/500mg Tablet contains an active component called Metformin and Vildagliptin. It is used for the management of type 2 diabetes mellitus, which is a chronic condition that affects...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
METFORMIN,VILDAGLIPTIN
Active Pharmaceutical Ingredient
Hosvilda M 50/500mg Tablet
$0.90
$0.73
Hosvilda M 50/500mg Tablet contains an active component called Metformin and Vildagliptin. It is used for the management of type 2 diabetes mellitus, which is a chronic condition that affects the way the body processes blood sugar (glucose). This medication can be used to help control high blood sugar levels. It may be used to improve insulin sensitivity in patients who are resistant to the effects of insulin. This medication might be used to manage blood sugar levels in individuals with overweight and obesity-related metabolic disorders. It should not be used in patients with known hypersensitivity or allergy to Hosvilda M 50/500mg Tablet or any other inactive ingredients in the medication. It should not be used in patients with severe renal impairment (creatinine clearance below 30 mL/min), as the kidneys primarily excrete this medication, and their clearance is reduced in patients with impaired renal function. Patients with a history of ketoacidosis, diabetic ketoacidosis, or lactic acidosis should not use this medication. It is not recommended for patients with severe liver impairment. Conditions such as heart failure, respiratory failure, recent myocardial infarction, and shock, which can lead to tissue hypoxia, are contraindications for the use of this medication. In patients who will be receiving iodinated contrast agents for radiologic studies, the use of this medication should be temporarily discontinued before or at the time of the procedure and not restarted until at least 48 hours after, provided that renal function has been re-evaluated and found to be stable. Elderly patients may be more susceptible to the side effects of this medication, particularly those related to kidney function. Regular monitoring of kidney function is essential. Hosvilda M 50/500mg Tablet is not recommended for use in children.
Active Pharmaceutical Ingredient
Uses
• Management of type 2 diabetes mellitus
• Control of hyperglycemia
• Improvement of insulin sensitivity
• Weight management
Benefits
Hosvilda M 50/500mg Tablet works by combining the mechanisms of its two active ingredients, Vildagliptin and Metformin, to manage type 2 diabetes mellitus. Vildagliptin functions by inhibiting the enzyme DPP-4, which increases active incretin hormone levels, stimulating insulin secretion and reducing glucagon release. Metformin reduces hepatic glucose production, enhances peripheral glucose uptake, and improves insulin sensitivity through AMPK activation. This combined action helps regulate blood sugar levels through complementary pathways.
Side Effects
Hosvilda M 50/500mg Tablet causes some side effects like all medications, although not everyone will experience them.
Most Common Side Effects
• Gastrointestinal disturbances
• Hypoglycemia
• Headache
• Dizziness
• Weakness or fatigue
• Metallic taste in the mouth
Common Side Effects
• Lactic acidosis
• Severe allergic reactions
How To Use
Hosvilda M 50/500mg Tablet is administered orally as tablets. The recommended starting dosage and any necessary dose adjustments are determined based on the specific condition being treated and the patient's response to the medication.
Safety Advice
• Breast Feeding: It is not safe to use this medication during breastfeeding. It is advised to discontinue either the medication or breastfeeding, depending on the importance of the drug to the mother.
• Alcohol: It is advisable to avoid excessive alcohol consumption while taking Hosvilda M 50/500mg Tablet, as it may increase the risk of lactic acidosis. Consult your healthcare provider regarding the consumption of alcohol while on this medication.
• Liver: If you have liver disorders, informing your healthcare provider before starting Hosvilda M 50/500mg Tablet is important.
• Lungs: Consult your healthcare provider if you have a history of lung conditions before using Hosvilda M 50/500mg Tablet.
• Driving: Hosvilda M 50/500mg Tablet may cause dizziness or drowsiness in some patients. If you experience these symptoms, consult your healthcare provider if you experience side effe
• Pregnancy: It is advisable to consult your healthcare provider before taking Hosvilda M 50/500mg Tablet, as it is not recommended during pregnancy
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.